Cargando…

Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients

OBJECTIVE: The incidence of acute pancreatitis (AP) is increasing. Twenty percent of AP patients with developing necrotizing pancreatitis (NP), while ~40–70% of NP patients develop potentially fatal infectious complications. When patients are suspected or confirmed infected pancreatic necrosis (IPN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiongdi, Ding, Yixuan, Qu, Yuanxu, Mei, Wentong, Guo, Yulin, Fang, Zhen, Qu, Chang, Gao, Chongchong, Cao, Feng, Li, Fei, Feng, Yulu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725918/
https://www.ncbi.nlm.nih.gov/pubmed/36483142
http://dx.doi.org/10.2147/IDR.S387384
_version_ 1784844669466705920
author Lu, Jiongdi
Ding, Yixuan
Qu, Yuanxu
Mei, Wentong
Guo, Yulin
Fang, Zhen
Qu, Chang
Gao, Chongchong
Cao, Feng
Li, Fei
Feng, Yulu
author_facet Lu, Jiongdi
Ding, Yixuan
Qu, Yuanxu
Mei, Wentong
Guo, Yulin
Fang, Zhen
Qu, Chang
Gao, Chongchong
Cao, Feng
Li, Fei
Feng, Yulu
author_sort Lu, Jiongdi
collection PubMed
description OBJECTIVE: The incidence of acute pancreatitis (AP) is increasing. Twenty percent of AP patients with developing necrotizing pancreatitis (NP), while ~40–70% of NP patients develop potentially fatal infectious complications. When patients are suspected or confirmed infected pancreatic necrosis (IPN), antibiotics should be administered timeously to control the infection, but long-term use of antibiotics can lead to multidrug-resistant bacteria (MDRB) infection and eventually to increased mortality. Our study aimed to determine the incidence of MDRB infection and evaluate the risk factors for MDRB infection in IPN patients. METHODS: Clinical data of IPN patients admitted to the general surgery department of Xuanwu Hospital of Capital Medical University between January 1, 2014, and December 31, 2021, were retrospectively analyzed. RESULTS: IPN patients (n = 267) were assigned to MDRB infection (n = 124) and non-MDRB infection (n = 143) groups. On admission, patients in the MDRB group had a higher modified computer tomography severity index (CTSI) score (P < 0.05), pancreatic necrosis degree, and PCT level (P < 0.05) than those in the non-MDRB group, and the prognosis of patients in MDRB group was poor. The most common gram-negative bacteria were Acinetobacter baumannii (n = 117), the most common gram-positive bacteria were Enterococcus faecium (n = 98), and the most common fungal infection was Candida albicans (n = 47). Multivariable analysis showed that complications of EPI (OR: 4.116, 95% CI: 1.381–12.271, P = 0.011), procalcitonin (PCT) level at admission (OR: 2.728, 95% CI: 1.502–4.954, P = 0.001), and degree of pancreatic necrosis (OR: 2.741, 95% CI: 1.109–6.775, P = 0.029) were independent risk factors for MDRB infection in IPN patients. CONCLUSION: We identified common infectious strains and risk factors for MDRB infection in IPN patients.
format Online
Article
Text
id pubmed-9725918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97259182022-12-07 Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients Lu, Jiongdi Ding, Yixuan Qu, Yuanxu Mei, Wentong Guo, Yulin Fang, Zhen Qu, Chang Gao, Chongchong Cao, Feng Li, Fei Feng, Yulu Infect Drug Resist Original Research OBJECTIVE: The incidence of acute pancreatitis (AP) is increasing. Twenty percent of AP patients with developing necrotizing pancreatitis (NP), while ~40–70% of NP patients develop potentially fatal infectious complications. When patients are suspected or confirmed infected pancreatic necrosis (IPN), antibiotics should be administered timeously to control the infection, but long-term use of antibiotics can lead to multidrug-resistant bacteria (MDRB) infection and eventually to increased mortality. Our study aimed to determine the incidence of MDRB infection and evaluate the risk factors for MDRB infection in IPN patients. METHODS: Clinical data of IPN patients admitted to the general surgery department of Xuanwu Hospital of Capital Medical University between January 1, 2014, and December 31, 2021, were retrospectively analyzed. RESULTS: IPN patients (n = 267) were assigned to MDRB infection (n = 124) and non-MDRB infection (n = 143) groups. On admission, patients in the MDRB group had a higher modified computer tomography severity index (CTSI) score (P < 0.05), pancreatic necrosis degree, and PCT level (P < 0.05) than those in the non-MDRB group, and the prognosis of patients in MDRB group was poor. The most common gram-negative bacteria were Acinetobacter baumannii (n = 117), the most common gram-positive bacteria were Enterococcus faecium (n = 98), and the most common fungal infection was Candida albicans (n = 47). Multivariable analysis showed that complications of EPI (OR: 4.116, 95% CI: 1.381–12.271, P = 0.011), procalcitonin (PCT) level at admission (OR: 2.728, 95% CI: 1.502–4.954, P = 0.001), and degree of pancreatic necrosis (OR: 2.741, 95% CI: 1.109–6.775, P = 0.029) were independent risk factors for MDRB infection in IPN patients. CONCLUSION: We identified common infectious strains and risk factors for MDRB infection in IPN patients. Dove 2022-12-02 /pmc/articles/PMC9725918/ /pubmed/36483142 http://dx.doi.org/10.2147/IDR.S387384 Text en © 2022 Lu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lu, Jiongdi
Ding, Yixuan
Qu, Yuanxu
Mei, Wentong
Guo, Yulin
Fang, Zhen
Qu, Chang
Gao, Chongchong
Cao, Feng
Li, Fei
Feng, Yulu
Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title_full Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title_fullStr Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title_full_unstemmed Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title_short Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients
title_sort risk factors and outcomes of multidrug-resistant bacteria infection in infected pancreatic necrosis patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9725918/
https://www.ncbi.nlm.nih.gov/pubmed/36483142
http://dx.doi.org/10.2147/IDR.S387384
work_keys_str_mv AT lujiongdi riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT dingyixuan riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT quyuanxu riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT meiwentong riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT guoyulin riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT fangzhen riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT quchang riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT gaochongchong riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT caofeng riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT lifei riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients
AT fengyulu riskfactorsandoutcomesofmultidrugresistantbacteriainfectionininfectedpancreaticnecrosispatients